🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is designed as a Phase III, multi-center trial of tandem autologo...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-12
Trial ID
NCT00075829
Relapse remains a principle cause of treatment failure for patients with ag...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-08
Trial ID
NCT01181271
Treatments Being Tested
In this study, researchers want to find out if using the VTD regimen, along...
Status
Withdrawn
Location
University of Arkansas for Medical Sciences
Start Date
2007-04
Trial ID
NCT00577668
Treatments Being Tested
The study is designed as a Phase III, multicenter trial of tandem autologou...
Status
Completed
Location
Arizona Cancer Center
Start Date
2010-05
Trial ID
NCT01109004
Treatments Being Tested
Factor VIII (FVIII) is a large plasma glycoprotein that participates in blo...
Status
Completed
Location
Christian Medical College Vellore Ranipet Campus
Start Date
2022-04-01
Trial ID
NCT05265767
The purpose of this study is to determine if double autologous then allogen...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2006-10
Trial ID
NCT00482053
Treatments Being Tested
To evaluate the toxicity and tolerability of this tandem autologous/allogen...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2009-05
Trial ID
NCT00899847
Treatments Being Tested
This phase II trial studies autologous peripheral blood stem cell transplan...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2010-03-18
Trial ID
NCT01008462
Treatments Being Tested
This is a standard of care treatment guideline for high risk or relapsed so...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2011-10-20
Trial ID
NCT01505569
This is a phase II study of autologous transplant for patients with Hodgkin...
Status
Recruiting
Location
Masonic Cancer Center, University of Minnesota
Start Date
2017-04-20
Trial ID
NCT03125642